It's an excellent question though. Japan fast-tracked on unmet need whereas the FDA is putting up road blocks, hand wringing and prevaricating.
Having educated them on stem cells and taken the long road, MSB has to educate them again.
MSB to dispute FDA finding in Type A meeting, page-478
-
- There are more pages in this discussion • 540 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.020(1.68%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.18 | $1.912M | 1.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 91648 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 60768 | 10 |
View Market Depth
| Last trade - 10.58am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |